GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Livongo Health Inc (NAS:LVGO) » Definitions » Net Issuance of Preferred Stock

Livongo Health (Livongo Health) Net Issuance of Preferred Stock : $0.0 Mil (TTM As of Sep. 2020)


View and export this data going back to 2019. Start your Free Trial

What is Livongo Health Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Livongo Health's net issuance of preferred for the three months ended in Sep. 2020 was $0.0 Mil. The number is 0, which means that Livongo Health has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Livongo Health's net issuance of preferred for the trailing twelve months (TTM) ended in Sep. 2020 was $0.0 Mil.

Livongo Health Net Issuance of Preferred Stock Historical Data

The historical data trend for Livongo Health's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livongo Health Net Issuance of Preferred Stock Chart

Livongo Health Annual Data
Trend Dec17 Dec18 Dec19
Net Issuance of Preferred Stock
52.35 104.75 -

Livongo Health Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Net Issuance of Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Livongo Health Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Livongo Health Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Livongo Health's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Livongo Health (Livongo Health) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Livongo Health Inc (NAS:LVGO) » Definitions » Net Issuance of Preferred Stock
Comparable Companies
PEN GMED BRKR TNDM IART NVRO WMGI NUVA SDC ITGR ABT MDT SYK BSX SZSE:300760 EW ZBH ALGN LSE:SN. BIO
Traded in Other Exchanges
N/A
Address
150 West Evelyn Avenue, Suite 150, Mountain View, CA, USA, 94041
Website
https://www.livongo.com
Livongo Health Inc provides a data science and technology enabled platform for detection of diabetes. Its additional solutions include Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company's client comprise of employers, health plans, government entities, and labor unions. Its operations are primarily located in the United States.
Executives
Lee Shapiro officer: Chief Financial Officer C/O ALLSCRIPTS HEALTCHARE SOLUTIONS, 2401 COMMERCE DR, LIBERTYVILLE IL 60048
Glen Tullman director, officer: Executive Chairman C/O LIVONGO HEALTH, INC., 150 WEST EVELYN AVENUE, SUITE 150, MOUNTAIN VIEW CA 94041
Karen L Daniel director 2801 80TH STREET, KENOSHA WI 53141
Philip E Green director C/O LIVONGO HEALTH, INC, 150 WEST EVELYN AVENUE, SUITE 150, MOUNTAIN VIEW CA 94041
Kenneth I Chenault 10 percent owner C/O GENERAL CATALYST, 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
Gc Venture Lh Manager, Llc 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR CAMBRIDGE MA 02138
Gc Partners Holdings, Lp 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
Gcgm Investment Holdings, Lp 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Group Management Holdings Gp, Llc 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Group Management Holdings, L.p. 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Gp Vi, Llc 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Gp Viii, Llc 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Partners Vi, L.p. 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Group Viii Supplemental, L.p. 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Group Viii, L.p. 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138